- CINDE Announces: Edwards Lifesciences Invests $100 million to Expand its Operations in Costa Rica
- Edwards Lifesciences To Host Earnings Conference Call On October 23, 2019
- Edwards SAPIEN 3 TAVR Demonstrates Significant Health Status Improvements for Low-Risk Patients
- Edwards Lifesciences To Present At The 2019 Wells Fargo Healthcare Conference
- Edwards SAPIEN 3 TAVR Receives FDA Approval For Low-Risk Patients
- Edwards Lifesciences Reports Second Quarter Results
- Edwards Lifesciences To Host Earnings Conference Call On July 23, 2019
- Edwards Comments On Updated TAVR National Coverage Determination
Edwards Lifesciences Corp (EW:NYQ) closed at 226.34, -1.67% below its 52-week high of 230.19, set on Oct 11, 2019.
136.44Oct 29 2018230.19Oct 11 2019
Markit short selling activity
|Market cap||47.55bn USD|
|EPS (TTM)||3.61 |
Data delayed at least 15 minutes, as of Oct 16 2019 23:30 BST.